BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

European and U.S. Cellulase Patents Granted to DIREVO Industrial Biotechnology GmbH


5/21/2013 9:13:11 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Cologne, Germany, May 21, 2013. Direvo Industrial Biotechnology GmbH (Direvo), an expert in enzyme development and optimization from Cologne, announced today the granting of U.S. and European Patents covering novel cellulase enzymes. Cellulase enzymes cleave plant based cellulose into small sugars and are used in numerous applications including production of pulp & paper, biofuels and synthesis of platform chemicals from renewable sources.

The granted patents, “POLYPEPTIDES HAVING CELLOBIOHYDROLASE II ACTIVITY”, describe improved cellulase enzymes having cellobiohydrolase II activity (CBH II) and methods to produce these enzymes. The CBH II enzymes have higher specific activity and show significantly increased performance compared to available cellulase enzymes.

Direvo´s CEO Jorg Riesmeier stated, “These granted patents will further strengthen our intellectual property portfolio protecting Direvo´s cutting edge technologies, providing additional licensing opportunities and enhancing our competitive market position.”

The invention arose from the unique and well-protected research and discovery platform BluServTM. The platform allows fast and target-orientated optimization of a vast variety of enzymes and microbial strains. The effectiveness of this platform has been proven in several projects and resulted in the market launch of superior enzyme products.

About Direvo Industrial Biotechnology GmbH:

Direvo is a biotechnology company with focus on the biomass conversion industry. Direvo identifies bottlenecks and weaknesses in current industrial processes in this sector and develops and implements biology-based solutions together with large and small industrial partners. Direvo’s products are newly designed enzymes and microorganisms of the highest quality that provide easy-to-implement, cost-effective solutions. Direvo’s contribution assures that partners stay competitive and profitable while supporting them to make the future cleaner, greener and safer. More information about Direvo is available on www.direvo.com.

Contact:

Klaudija Milos

DIREVO Industrial Biotechnology GmbH

Nattermannallee 1

50829 Köln (Cologne)

Germany

Phone +49 221-47448-113

Fax +49 221-47448-111

E-Mail klaudija.milos@direvo.com

Internet www.direvo.com



Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES